The NOD (non-obese diabetic) mouse develops Type I diabetes mellitus secondary to autoimmune beta cell destruction. Our initial breeding studies indicate that these animals have more than one diabetogenic gene, and that a recessive gene necessary for development of diabetes is contained within the NOD major histocompatibility region. To date in crosses of NOD mice to C3H (H-2K) mice no F1 animals have developed diabetes (0/81) and all F2 or backcross animals (9/9) which have become diabetic are homozygous for the NOD H-2 haplotype. Initial characterization of the NOD H-2 region suggests that it is a natural """"""""recombinant"""""""" (Kd, IA-alphad, IA-betad, IE-alpha non-d non-b, C4 non-d non-b, Db). Currently the actual gene(s) within the MHC contributing to diabetes susceptibility is unknown. We propose to localize and identify the MHC diabetogenic gene of the NOD mouse and to study immunologic effector mechanisms in these animals. In particular we propose to, 1) confirm with further breeding studies the recessive nature of the NOD diabetogenic MHC gene and transfer """"""""all"""""""" the NOD's diabetogenic genes onto a C3H background. 2) Determine whether defined H-2 haplotyes (H-2b C57/bl, H-2d Balb/c) or H-2 recombinants (three strains of H-2g) have an analogous diabetogenic gene. 3) Analyze in detail the H-2 region of the NOD using a) monoclonal antibodies to class I and class II antigens, b) T cell clones of known H-2 restriction, and c) a series of DNA probes for IA-alpha, IA-beta, IE-beta, complement and class I genes. 4) Both monoclonal anti-islet autoantibodies and T cell autoreactive cell lines will be produced to define islet target antigens of the NOD mouse and the relationship of these effector mechanisms to the MHC recessive gene. Finally if the NOD's MHC diabetogenic gene is isolated and characterized, we will attmept to prevent or produce anti-islet autoimmunity and diabetes by introducing through gene transfer (transgenic mice) a relevant H-2 non-diabetogenic gene or the NOD """"""""diabetogenic"""""""" gene and evaluate its influence in breeding studies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK036641-03
Application #
3235129
Study Section
Immunobiology Study Section (IMB)
Project Start
1986-02-01
Project End
1989-06-30
Budget Start
1988-02-01
Budget End
1989-06-30
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Joslin Diabetes Center
Department
Type
DUNS #
071723084
City
Boston
State
MA
Country
United States
Zip Code
02215
Dotta, F; Tiberti, C; Previti, M et al. (1993) Rat pancreatic ganglioside expression: differences between a model of autoimmune islet B cell destruction and a normal strain. Clin Immunol Immunopathol 66:143-9
Hattori, M; Fukuda, M; Ichikawa, T et al. (1990) A single recessive non-MHC diabetogenic gene determines the development of insulitis in the presence of an MHC-linked diabetogenic gene in NOD mice. J Autoimmun 3:1-10
Lipes, M A; Eisenbarth, G S (1990) Transgenic mouse models of type I diabetes. Diabetes 39:879-84
Wilson, K; Eisenbarth, G S (1990) Immunopathogenesis and immunotherapy of type 1 diabetes. Annu Rev Med 41:497-508
Ziegler, A G; Vardi, P; Gross, D J et al. (1989) Production of insulin antibodies by mice rejecting insulin transfected cells. J Autoimmun 2:219-27
Dotta, F; Colman, P G; Lombardi, D et al. (1989) Ganglioside expression in human pancreatic islets. Diabetes 38:1478-83
Ziegler, A G; Ziegler, R; Vardi, P et al. (1989) Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type I diabetes. Diabetes 38:1320-5
Zielasek, J; Jackson, R A; Eisenbarth, G S (1989) The potentially simple mathematics of type I diabetes. Clin Immunol Immunopathol 52:347-65
Herskowitz, R D; Jackson, R A; Soeldner, J S et al. (1989) Pilot trial to prevent type I diabetes: progression to overt IDDM despite oral nicotinamide. J Autoimmun 2:733-7
Eisenbarth, G S; Nayak, R C; Rabinowe, S L (1988) Type I diabetes as a chronic autoimmune disease. J Diabet Complications 2:54-8

Showing the most recent 10 out of 12 publications